A meta-analysis of metabolic enzyme expression across diverse tumor types identified pyrroline-5-carboxylate reductase (PYCR1), the principal enzyme in proline biosynthesis, as one of the most commonly overexpressed genes in tumors (Nilsson et al., 2014). This evidence concerns the gene PYCR1 and neoplasm.